The stock of Acadia Healthcare Company Inc (NASDAQ:ACHC) hit a new 52-week low and has $39.82 target or 7.00% below today’s $42.82 share price. The 5 months bearish chart indicates high risk for the $3.64B company. The 1-year low was reported on Oct, 17 by Barchart.com. If the $39.82 price target is reached, the company will be worth $254.80 million less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 433,151 shares traded hands. Acadia Healthcare Company Inc (NASDAQ:ACHC) has declined 21.81% since March 14, 2016 and is downtrending. It has underperformed by 27.42% the S&P500.
Analysts await Acadia Healthcare Company Inc (NASDAQ:ACHC) to report earnings on November, 1. They expect $0.67 EPS, up 8.06% or $0.05 from last year’s $0.62 per share. ACHC’s profit will be $56.93M for 15.99 P/E if the $0.67 EPS becomes a reality. After $0.73 actual EPS reported by Acadia Healthcare Company Inc for the previous quarter, Wall Street now forecasts -8.22% negative EPS growth.
Acadia Healthcare Company Inc (NASDAQ:ACHC) Ratings Coverage
Out of 9 analysts covering Acadia Healthcare (NASDAQ:ACHC), 8 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 89% are positive. $100 is the highest target while $66 is the lowest. The $82 average target is 91.50% above today’s ($42.82) stock price. Acadia Healthcare has been the topic of 14 analyst reports since August 6, 2015 according to StockzIntelligence Inc. JP Morgan initiated the shares of ACHC in a report on Wednesday, September 16 with “Neutral” rating. Mizuho maintained the shares of ACHC in a report on Thursday, August 6 with “Buy” rating. The firm earned “Outperform” rating on Monday, August 1 by RBC Capital Markets. The stock of Acadia Healthcare Company Inc (NASDAQ:ACHC) earned “Outperform” rating by Robert W. Baird on Thursday, September 15. The stock has “Buy” rating given by Mizuho on Friday, April 29. Leerink Swann initiated Acadia Healthcare Company Inc (NASDAQ:ACHC) on Tuesday, September 1 with “Outperform” rating. Zacks upgraded it to “Hold” rating and $95 target price in Thursday, August 6 report. Cantor Fitzgerald maintained the shares of ACHC in a report on Thursday, August 6 with “Buy” rating. The rating was initiated by KeyBanc Capital Markets on Monday, February 1 with “Overweight”.
According to Zacks Investment Research, “Acadia Healthcare Company, Inc. provides inpatient behavioral health care services. It provides psychiatric and chemical dependency services, including inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs. Acadia Healthcare Company, Inc. is headquartered in Franklin, Tennessee.”
Insitutional Activity: The institutional sentiment decreased to 1.25 in 2016 Q2. Its down 0.09, from 1.34 in 2016Q1. The ratio dropped, as 32 funds sold all Acadia Healthcare Company Inc shares owned while 70 reduced positions. 34 funds bought stakes while 94 increased positions. They now own 85.76 million shares or 4.92% more from 81.74 million shares in 2016Q1.
State Of Wisconsin Inv Board holds 286,252 shares or 0.06% of its portfolio. American Intll Group Incorporated has invested 0% of its portfolio in Acadia Healthcare Company Inc (NASDAQ:ACHC). Nicholas Investment Lp last reported 16,433 shares in the company. Neuberger Berman Grp Ltd last reported 249,751 shares in the company. Wells Fargo And Mn last reported 5.28 million shares in the company. Old Fincl Bank In holds 0.02% or 4,901 shares in its portfolio. Moreover, Springbok Cap Management Ltd Liability Corp has 0.02% invested in Acadia Healthcare Company Inc (NASDAQ:ACHC) for 2,241 shares. Tiaa Cref Inv Mngmt Ltd Liability Corp holds 0.01% or 350,693 shares in its portfolio. Sectoral Asset last reported 480,605 shares in the company. Agf Invests Incorporated last reported 0.05% of its portfolio in the stock. The New York-based Mutual Of America Capital Mngmt Ltd Liability has invested 0.15% in Acadia Healthcare Company Inc (NASDAQ:ACHC). Driehaus Limited has 51,659 shares for 0.1% of their US portfolio. Calvert Inv Mgmt holds 4,192 shares or 0.01% of its portfolio. Blackrock Institutional Trust Na reported 1.82M shares or 0.02% of all its holdings. Sirios Capital Mgmt Ltd Partnership accumulated 2.25% or 846,028 shares.
Insider Transactions: Since August 5, 2016, the stock had 0 insider purchases, and 10 insider sales for $139.31 million net activity. Fincher Ronald Morgan sold $462,536 worth of stock. $22.14 million worth of shares were sold by WAUD CAPITAL PARTNERS III – L.L.C. on Wednesday, September 14. 3,626 shares were sold by GOLDBERG RANDALL P, worth $190,044. Duckworth David M. had sold 16,670 shares worth $905,681 on Monday, August 15. WAUD CAPITAL PARTNERS II – L.L.C. also sold $40.10M worth of Acadia Healthcare Company Inc (NASDAQ:ACHC) on Wednesday, September 14. WAUD REEVE B sold $4.35M worth of stock or 84,208 shares.
ACHC Company Profile
Acadia Healthcare Company, Inc., incorporated on October 24, 2005, is a well-known provider of behavioral healthcare services. The Firm operates in two divisions: U.S. Facilities and U.K. Facilities. The Firm develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico. The Firm operates approximately 260 behavioral healthcare facilities with over 9,900 beds in over 40 states, the United Kingdom and Puerto Rico.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.